$131.78
0.030.02%
Pre-Market: 6:06 PM EDT
Comments
Loading...
Latest Intra-Cellular Therapies Stock News | NASDAQ:ITCI | Benzinga
Get the latest news on Intra-Cellular Therapies stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Intra-Cellular Therapies performance
Categories: All
Friday, March 07, 2025
Monday, February 24, 2025
Friday, February 21, 2025
Tuesday, February 18, 2025
Friday, January 31, 2025
Wednesday, January 22, 2025
Tuesday, January 21, 2025
Sunday, January 19, 2025
Tuesday, January 14, 2025
Monday, January 13, 2025
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Intra-Cellular Therapies Stock Is Surging Monday: What's Going On?
- Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge
- Crude Oil Surges 3%; Abercrombie & Fitch Shares Plunge
- Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday
- Needham Downgrades Intra-Cellular Therapies t...
- Like Bristol-Myers Squibb And AbbVie, Johnson & Johnson Seeks To Bolster Neuropsychiatric Portfolio With $15 Billion Deal
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Johnson & Johnson Says Intra-Cellular Acquisi...
- Intra-Cellular Therapies shares are trading h...
- Johnson & Johnson Agrees To Acquire Intra-cel...
- Johnson & Johnson Has Agreed To Acquire Intra...
- Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket